Concepedia
3
Publications
154
Citations
H-Index
2013
Active since
Affiliations
Bayer (Germany)(Current)
Singapore General Hospital
Bayer (United States)
University of the Witwatersrand
Marion Hardtke is an author at Bayer (Germany).
Publications per year
2013–2016
Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII
Mark T. Reding, Hannah Jia Hui Ng, Lone Hvitfeldt Poulsen et al. · Journal of Thrombosis and Haemostasis · 2016 · 115 citations · Full text
<scp>TRUST</scp> trial: <scp>BAY</scp> 86‐6150 use in haemophilia with inhibitors and assessment for immunogenicity
Johnny Mahlangu, P. de Paz, Marion Hardtke et al. · Haemophilia · 2016 · 28 citations · Full text
The TRUST Trial: Anti-Drug Antibody Formation In a Patient With Hemophilia With Inhibitors After Receiving The Activated Factor VII Product Bay 86-6150
Johnny Mahlangu, Pei Lin Koh, Heng Joo Ng et al. · Blood · 2013 · 11 citations
Rows per page
1–3 of 3